Scynexis (SCYX) Capital Expenditures (QoQ) (2013 - 2021)
Scynexis (SCYX) Capital Expenditures (QoQ) (2013 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Scynexis | 21.55 Mn | -15.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -303.40% |
| Sep 30, 2021 | 64.34% |
| Jun 30, 2021 | -19.66% |
| Mar 31, 2021 | 4,550.00% |
| Dec 31, 2020 | -200.00% |
| Dec 31, 2018 | 31.34% |
| Sep 30, 2018 | -83.25% |
| Jun 30, 2018 | 3,900.00% |
| Mar 31, 2017 | -33.33% |
| Dec 31, 2016 | -70.00% |
| Mar 31, 2016 | -66.67% |
| Dec 31, 2015 | 110.00% |
| Sep 30, 2015 | -94.38% |
| Jun 30, 2015 | 108.19% |
| Mar 31, 2015 | 137.50% |
| Dec 31, 2014 | -76.70% |
| Sep 30, 2014 | 24.10% |
| Jun 30, 2014 | 236.49% |
| Mar 31, 2014 | 21.31% |
| Dec 31, 2013 | 7.02% |